Pilot clinical trial with memantine for cognitive deficits in patients with multiple sclerosis
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2012
At a glance
- Drugs Memantine (Primary)
- Indications Cognition disorders; Multiple sclerosis
- Focus Pharmacodynamics; Therapeutic Use
- 07 Jun 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 09 Apr 2008 New trial record.